Drug Type Therapeutic vaccine |
Synonyms HCVax, Lentiviral based HCV immunotherapy (GeneCure), Therapeutic HCV vaccine (GeneCure) + [1] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C, Chronic | Phase 1 | United States | 20 Apr 2021 |